Le Lézard
Classified in: Health, Covid-19 virus
Subjects: SVY, PSF, CPG

COVID-19 Pandemic - The government presents its daily update


QUÉBEC CITY, March 7, 2022 /CNW Telbec/ - The most recent data on the evolution of COVID-19, in the last 24 hours, in Québec show:

*Note that the number of cases listed is not representative of the situation since access to screening centres is restricted to priority clienteles.

Vaccination

To follow the evolution of the data on a daily basis, consult the open data or the INSPQ website at https://www.donneesquebec.ca/recherche/fr/organization/msss or at https://www.inspq.qc.ca/covid-19/donnees. Note that certain data, especially the number of cases, deaths and doses administered, may be subject to daily readjustment for previous days, given that a catch-up is necessary due to a delay in data entry.

A reminder concerning public health instructions:

To limit the spread of the coronavirus as much as possible, it is important to follow basic preventive measures such as hand washing, physical distancing, wearing a face covering and following the instructions in effect.

Remember that in the event of symptoms, it is always essential to isolate yourself and consult one of the self-care guides or call 1-877-644-4545 (or the telephone code corresponding to the region concerned) to find out the measures to be taken.

Related links:

SOURCE Ministère de la Santé et des Services sociaux


These press releases may also interest you

at 21:00
Generation Mining Limited ("Gen Mining" or the "Company") is pleased to announce that it has filed a final short form base shelf prospectus (the "Prospectus") with the securities regulatory authorities in each of the provinces and territories of...

at 17:45
Las Vegas Sands has contributed $225,000 through Sands Cares to the Asian Community Development Council (ACDC) for three key ACDC offerings including the Healthy Asian Pacific Islanders (HAPI) Medical Center, the API Language Link and developmental...

at 17:30
Modern, high-quality research facilities and equipment are essential for breakthroughs in Canadian research and science. These laboratories and research centres are where medical and other scientific breakthroughs are born, helping to solve...

at 17:09
Johnson & Johnson announced today first data from the Phase 3 PALOMA-3 study evaluating...

at 16:57
Johnson & Johnson today announced new data from the Phase 3 MARIPOSA study demonstrating the benefit of first-line treatment with RYBREVANT® (amivantamab-vmjw) in combination with lazertinib in patients with...

at 16:25
PulteGroup, Inc. (the "Company") today announced the pricing for its previously announced tender offers to purchase for cash up to $300,000,000 aggregate principal amount (the "Aggregate Tender Cap") of the Company's 5.500% Senior Notes due 2026...



News published on and distributed by: